Evaluating complications of anticoagulant treatment in cancer patients with blood clots
Thromboembolic and Hemorrhagic Complications of Anticoagulant Treatment in Patients With CAT (Cancer Associated Thrombosis)
This study looks at how often blood clots and bleeding problems happen in cancer patients who are being treated with blood thinners.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna Academic / other |
| Locations | 2 sites (Bologna and 1 other locations) |
| Trial ID | NCT06714734 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the frequency of thrombotic and hemorrhagic complications in adult patients diagnosed with venous thromboembolism related to neoplasia. It will involve both retrospective and prospective data collection from patients treated at two medical centers in Italy. The study will follow patients according to standard clinical practices and will not alter their diagnostic or therapeutic pathways based on study results. Data analysis is expected to conclude by the end of 2027.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with a diagnosis of venous thromboembolism in the context of neoplasia.
Not a fit: Patients without a diagnosis of venous thromboembolism or those not related to neoplasia may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the understanding of anticoagulant treatment safety in cancer patients, potentially leading to better management strategies.
How similar studies have performed: While this study is observational, similar studies have shown varying degrees of success in understanding anticoagulant complications in cancer patients.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * Diagnosis of venous thrombosis at any site * Diagnosis of CVC-related venous thrombosis * Diagnosis of pulmonary embolism, both symptomatic and incidental * Diagnosis of solid or hematological neoplasm, either under treatment or active * Obtaining of Informed Consent Exclusion Criteria: * None
Where this trial is running
Bologna and 1 other locations
- IRCCS Azianda Ospedaliero-Universitaria di Bologna — Bologna, Italy (Recruiting)
- IRCCS Arcispedale S. Maria Nuova di Reggio Emilia — Reggio Emilia, Italy (Recruiting)
Study contacts
- Principal investigator: Benilde Cosmi, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Benilde Cosmi, MD
- Email: benilde.cosmi@unibo.it
- Phone: 0512142483
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.